Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)

Clinical trial NCT01352338 · COMPLETED

Trial details

NCT number: NCT01352338
Sponsor: UMC Utrecht
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2011-08-01
Primary completion: 2014-11-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.